June 24 (Reuters) - Celyad Oncology SA CYAD.BR:
CELYAD ONCOLOGY ANNOUNCES STRATEGIC REVIEW
CELYAD ONCOLOGY SA - REVIEW INCLUDES POTENTIAL ASSET SALES, RESTRUCTURING, MERGERS
CELYAD ONCOLOGY SA - EXISTING CASH TO FUND OPERATIONS ONLY INTO Q3 2025
CELYAD ONCOLOGY SA - INITIATES REFINANCING DISCUSSIONS WITH INVESTORS AND ADVISORS
CELYAD ONCOLOGY SA - ADDITIONAL FINANCING OR STRATEGIC DEAL LIKELY NEEDED
Source text: ID:nBw55jTlga
Further company coverage: CYAD.BR
((Reuters.Briefs@thomsonreuters.com;))